08/27/2024
3:45 PM | ClearPoint Neuro, Inc. (Subject)
ClearPoint Neuro, Inc. (Subject)
PTC Therapeutics (Filed by)
| Form SC 13D/A | |
08/08/2024
3:35 PM | PTC Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/18/2024
4:20 PM | Gravier Pierre (Reporting)
PTC Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2024
2:14 PM | Gravier Pierre (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/28/2024
6:00 AM | PTC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2024
6:55 AM | PTC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2024
4:20 PM | PTC Therapeutics (Issuer)
ZELDIS JEROME B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
05/22/2024
9:12 AM | PTC Therapeutics (Subject)
ZELDIS JEROME B (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/20/2024
6:20 AM | PTC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2024
4:20 PM | PTC Therapeutics (Issuer)
SOUTHWELL DAVID P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
4:20 PM | Golden Lee Scott (Reporting)
PTC Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
2:30 PM | Golden Lee Scott (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/22/2024
4:20 PM | Klein Matthew B. (Reporting)
PTC Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
4:20 PM | Klein Matthew B. (Reporting)
PTC Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
4:20 PM | Pauwels Eric (Reporting)
PTC Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
2:17 PM | Klein Matthew B. (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/17/2024
2:24 PM | Pauwels Eric (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/17/2024
2:13 PM | Klein Matthew B. (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024
4:16 PM | Golden Lee Scott (Reporting)
PTC Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
2:58 PM | Golden Lee Scott (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
3:36 PM | PTC Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/16/2024
3:20 PM | PTC Therapeutics (Issuer)
SOUTHWELL DAVID P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:20 PM | Bell William F. Jr. (Reporting)
PTC Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:25 PM | PTC Therapeutics (Issuer)
SCHMERTZLER MICHAEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:10 PM | Boulding Mark Elliott (Reporting)
PTC Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:10 PM | Klein Matthew B. (Reporting)
PTC Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:10 PM | Golden Lee Scott (Reporting)
PTC Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:11 PM | Gravier Pierre (Reporting)
PTC Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:16 PM | Okey Stephanie (Reporting)
PTC Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
2:50 PM | ARMISTICE CAPITAL, LLC (Filed by)
PTC Therapeutics (Subject)
| Form SC 13G | |
02/14/2024
6:13 AM | PTC Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
02/08/2024
9:17 AM | PTC Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
01/30/2024
2:17 PM | PTC Therapeutics (Subject)
Utter Christine Marie (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2024
2:18 PM | Almstead Neil Gregory (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2024
2:18 PM | Almstead Zheng Yang (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2024
2:25 PM | Pauwels Eric (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2024
3:30 PM | Jacobson Allan Steven (Reporting)
PTC Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
12:11 PM | PTC Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/22/2024
3:11 PM | Jacobson Allan Steven (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2024
3:06 PM | Golden Lee Scott (Reporting)
PTC Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
3:08 PM | Klein Matthew B. (Reporting)
PTC Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
The solution to fast food’s wage hike crisis (Ad) Shake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post.
With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032. Learn more about this much-needed advancement and investment opportunity here. |
01/10/2024
3:09 PM | Pauwels Eric (Reporting)
PTC Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
3:10 PM | PTC Therapeutics (Issuer)
SCHMERTZLER MICHAEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
3:11 PM | PTC Therapeutics (Issuer)
Utter Christine Marie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
7:53 AM | FMR LLC (Filed by)
PTC Therapeutics (Subject)
| Form SC 13G/A | |
01/09/2024
4:46 PM | Almstead Zheng Yang (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024
3:35 PM | Klein Matthew B. (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024
3:29 PM | Klein Matthew B. (Reporting)
PTC Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
3:30 PM | Golden Lee Scott (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024
3:33 PM | Pauwels Eric (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024
3:16 PM | Almstead Neil Gregory (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024
3:17 PM | Boulding Mark Elliott (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024
3:23 PM | PTC Therapeutics (Subject)
Utter Christine Marie (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
3:47 PM | Almstead Zheng Yang (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
3:35 PM | BlackRock Inc. (Filed by)
PTC Therapeutics (Subject)
| Form SC 13G/A | |
01/08/2024
3:37 PM | Almstead Neil Gregory (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
3:46 PM | PTC Therapeutics (Subject)
Utter Christine Marie (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
3:29 PM | Boulding Mark Elliott (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
3:34 PM | Klein Matthew B. (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
3:35 PM | Golden Lee Scott (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
8:46 AM | PTC Therapeutics (Subject)
SCHMERTZLER MICHAEL (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
8:27 AM | PTC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
2:17 PM | Klein Matthew B. (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/28/2023
4:12 PM | Klein Matthew B. (Reporting)
PTC Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
3:38 PM | Gravier Pierre (Reporting)
PTC Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
8:02 AM | FMR LLC (Filed by)
PTC Therapeutics (Subject)
| Form SC 13G/A | |
11/07/2023
3:16 PM | PTC Therapeutics (Filer)
| Form POSASR | |
10/30/2023
8:05 AM | Camber Capital Management LP (Filed by)
PTC Therapeutics (Subject)
| Form SC 13G | |
10/26/2023
3:34 PM | PTC Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/19/2023
3:15 PM | PTC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/19/2023
7:03 AM | PTC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/28/2023
3:45 PM | PTC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/22/2023
8:00 AM | PTC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/15/2023
5:15 AM | PTC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
